CIK 0001836564 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in I0 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 6-K | 6-K | 2026-12-31 |
| 2026-10-08 | 6-K | 6-K | 2026-12-31 |
| 2026-08-14 | 6-K | 6-K | 2026-12-31 |
| 2026-08-13 | 6-K | 6-K | 2026-06-30 |
| 2026-07-22 | 6-K | 6-K | 2026-12-31 |
| 2026-06-25 | 6-K | 6-K | 2026-12-31 |
| 2026-06-16 | EFFECT | EFFECT items ,, | |
| 2026-06-16 | 424B3 | PROSPECTUS | |
| 2026-06-12 | CORRESP | CORRESP | |
| 2026-06-11 | UPLOAD | UPLOAD | |
| 2026-06-05 | 6-K | 6-K | 2026-12-31 |
| 2026-06-04 | F-3 | REGISTRATION STATEMENT FOR SPECIFIED TRANSACTIONS BY CERTAIN FOREIGN PRIVATE ISS | |
| 2026-06-01 | 6-K | 6-K | 2026-12-31 |
| 2026-05-13 | 6-K | 6-K | 2026-03-31 |
| 2026-05-12 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-05-12 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-05 | 6-K | 6-K | 2026-12-31 |
| 2026-04-30 | 6-K | 6-K | 2026-12-31 |
| 2026-03-26 | 6-K | 6-K | 2026-12-31 |
| 2026-03-23 | 6-K | 6-K | 2026-12-31 |
| 2026-03-18 | 6-K | 6-K | 2026-12-31 |
| 2026-03-17 | 20-F | 20-F | 2025-12-31 |
| 2026-03-10 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-03-09 | 6-K | 6-K | 2026-12-31 |
| 2026-03-02 | 6-K | 6-K | 2026-12-31 |
Forms on file (last 1,000): 6-K 201, CORRESP 9, UPLOAD 8, EFFECT 6, 20-F 5, F-3 3, SCHEDULE 13D/A 3, SC 13G 3. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VALN (0.002 USD), /gw/filings/filings?ticker=VALN&form=8-K, /gw/filings/facts?ticker=VALN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange